Ankylosing spondylitis can be controlled by timely and standardized treatment. It is a chronic inflammatory disease that mainly affects the iliac joints, spine and surrounding soft tissues, and the disease progression can be controlled by medication and physical therapy.
Ankylosing spondylitis is mostly related to genetic and environmental factors. The principle of treatment is early detection and early treatment, which can be achieved by using anti-rheumatic drugs such as methotrexate and thalidomide to inhibit immune response and control the disease progression, and also by using biologics such as etanercept and adalimumab to delay the disease progression, and by training to enhance the flexibility and strength of the joints as well as the lung capacity.
Once diagnosed with ankylosing spondylitis, patients should receive standardized treatment in a timely manner in accordance with the doctor’s instructions. Timely treatment can be achieved to control the disease and slow down its progression, and appropriate aerobic exercise can be carried out in daily life, and regular review is needed, so please follow the doctor’s instructions on the use of medication.